Published in Clin J Am Soc Nephrol on March 05, 2008
Primary stent placement for iliac artery chronic total occlusions. Surg Today (2010) 1.01
Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag (2008) 0.89
Cilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg (2014) 0.82
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94
Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg (2000) 5.50
Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med (1974) 4.23
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med (1998) 3.59
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int (2000) 2.72
The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol (1999) 2.48
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 2.35
Coronary stent restenosis in patients treated with cilostazol. Circulation (2005) 1.73
Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol (2001) 1.70
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol (2004) 1.55
The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis (2002) 1.46
The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg (2005) 1.32
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg (2005) 1.30
Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol (1992) 1.17
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension (2000) 1.13
Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation (1999) 1.12
Effects of cilostazol on angiographic restenosis after coronary stent placement. Am J Cardiol (2000) 1.04
Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J (2008) 1.04
Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology (1988) 1.04
Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study. Arzneimittelforschung (1987) 0.99
Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int (2001) 0.98
High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg (1997) 0.97
Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension (1999) 0.95
Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model. Diabetologia (2001) 0.92
Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis. Am J Cardiol (1998) 0.89
Dialysis membranes and coagulation system. Blood Purif (1986) 0.88
Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv (2007) 0.85
Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron (1986) 0.83
Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis. Am Heart J (2002) 0.81
Success rate of implantation and mid-term outcomes of the sirolimus-eluting stent. Circ J (2007) 0.81
Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant (2007) 0.80
Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J (2006) 0.79
Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J (2005) 0.79
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet (2002) 7.11
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol (2007) 3.08
Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes (2006) 2.85
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res (2004) 2.72
Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58
Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ Res (2007) 2.57
Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis (2010) 2.47
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol (2008) 2.39
Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol (2004) 2.33
Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun (2013) 2.29
Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension (2006) 2.24
Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol (2007) 2.20
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20
Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant (2011) 2.17
Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation. Circ Arrhythm Electrophysiol (2010) 2.06
Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension (2006) 2.03
Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation. Europace (2008) 2.02
Cardiovascular events increased at normal and high-normal blood pressure in young and middle-aged Japanese male smokers but not in nonsmokers. J Hypertens (2013) 2.01
Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation (2004) 2.00
Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol (2002) 1.98
Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol (2003) 1.97
Congenital dermoid cyst at the anterior fontanelle: neuroimaging before and after fontanelle closure. J Nippon Med Sch (2012) 1.97
Perforative peritonitis caused by appendicitis in a patient on peritoneal dialysis. Intern Med (2013) 1.97
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95
Exercise training alters left ventricular geometry and attenuates heart failure in dahl salt-sensitive hypertensive rats. Hypertension (2009) 1.93
Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias. Heart Rhythm (2010) 1.91
Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm (2009) 1.83
Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation (2012) 1.81
Uric acid and left ventricular hypertrophy in Japanese men. Circ J (2009) 1.79
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest (2003) 1.79
Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J (2004) 1.74
Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A (2012) 1.72
Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int (2009) 1.72
Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart Rhythm (2007) 1.71
Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome. J Nucl Med (2010) 1.71
Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J (2008) 1.70
Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res (2008) 1.70
Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer (2002) 1.69
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol (2009) 1.69
Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol (2005) 1.68
H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation (2013) 1.65
Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res (2005) 1.63
Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats. Hypertension (2005) 1.62
Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation (2004) 1.61
Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol (2005) 1.60
Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J (2006) 1.60
Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period. Mol Genet Metab (2008) 1.59
Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study. Hypertension (2012) 1.59
Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm. Circulation (2011) 1.58
Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int (2008) 1.58
Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J Am Soc Nephrol (2008) 1.57
Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome. Hypertension (2012) 1.57
Increased (99m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients. J Am Coll Cardiol (2013) 1.57
Retracted Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. Am J Nephrol (2004) 1.57
Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J (2011) 1.56
Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J Am Coll Cardiol (2004) 1.56
Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res (2007) 1.56
Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. JACC Cardiovasc Imaging (2008) 1.56
Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol (2009) 1.56
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology (2013) 1.56
Circulating cathepsin K as a potential novel biomarker of coronary artery disease. Atherosclerosis (2013) 1.56
Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J (2007) 1.55
Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation. Hypertension (2007) 1.55
The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart J (2008) 1.54
Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev (2009) 1.53
Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol (2008) 1.53
Adiponectin and cardiovascular disease. Circ J (2009) 1.52
B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol (2006) 1.52
Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging (2008) 1.51
Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes. Circ Cardiovasc Interv (2011) 1.51
Electrophysiologic characteristics and outcome of segmental ostial superior vena cava isolation in patients with paroxysmal atrial fibrillation initiated by superior vena cava ectopy: comparison with pulmonary vein isolation. J Electrocardiol (2007) 1.51
Epicardial fat volume correlates with severity of coronary artery disease in nonobese patients. J Cardiovasc Med (Hagerstown) (2014) 1.50
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease. Am Heart J (2003) 1.50
Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma. Leuk Lymphoma (2014) 1.50